Because renal cells express ACE2, the kidneys become one of the main targets for SARS-CoV-2, and changes in renal metabolism may underlie the mechanisms by which SARS-CoV-2 induces AKI and aggravates clinical conditions of COVID-19 patients. The gene discussed is ACE2; the disease is COVID-19.